Publication | Closed Access

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

Chronic PhaseHematological MalignancyChronic Myeloid LeukemiaOncologyOptimized PredictorEngineeringMedicineHematologyCell BiologySystems BiologyMolecular DiagnosticsRadiation OncologyMyeloid Neoplasia